EchoSolv gives physicians access to an easy-to-use dashboard, adjustable alerts, and a deeper view of risk probability to support earlier identification of mortality-risk in patients who might benefit from therapeutic intervention or more proactive vigilance.
Conditions assessed include:
- Aortic Stenosis (complete)
- Mitral Regurgitation (Q2 2023)
This proprietary cloud-based platform is backed by the latest in medical technology, AI, and machine learning. This innovative decision-support tool is designed to highlight probability indicators for structural heart disease using echocardiographic measurement data from a standard cardiothoracic ultrasound.
Augmented by additional checks and validated in clinical trials, EchoSolv is as comprehensive as it is easy to integrate into your practice.